Navigation Links
Aethlon Medical Discloses CEO Interview
Date:1/29/2013

and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of Aethlon Medical, Inc. to be materially different from any future results, performance, or achievements expressed or implied by the forward-looking statements. Such potential risks and uncertainties include, without limitation, that the FDA will not approve the initiation of the Company's clinical programs or provide market clearance of the company's products, future human studies whether revenue or non-revenue generating from either compassionate use or non-compassionate use of the Aethlon ADAPT™ system or the Aethlon Hemopurifier® as an adjunct therapy to improve patient responsiveness to established cancer or hepatitis C therapies or sepsis therapies or as a standalone cancer or hepatitis C therapy or standalone sepsis therapy, the Company's ability to raise capital when needed, the Company's ability to complete the development of its planned products, the Company's ability to manufacture its products either internally or through outside companies and provide its services, the impact of government regulations, patent protection on the Company's proprietary technology, product liability exposure, uncertainty of market acceptance, competition, technological change, and other risk factors. In such instances, actual results could differ materially as a result of a variety of factors, including the risks associated with the effect of changing economic conditions and other risk factors detailed in the Company's Securities and Exchange Commission filings. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise.

Contacts:

James A. Joyce    
Chairman and CEO    
858.459.7800 x301    
jj@aethlonmedical.com
'/>"/>

SOURCE Aethlon Medical, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Aethlon Medical Note: An Unprecedented Data Point, The Single-Treatment Capture of Hepatitis C Virus (HCV) by the Aethlon Hemopurifier®
2. Aethlon Medical Note: Marc Robins Joins the Aethlon Team
3. Aethlon Medical Note: Fiscal Year Revenue Guidance
4. Aethlon Medical Reports Undetectable Hepatitis C Virus (HCV) in Genotype 1, Genotype 3, and Genotype 5 Patients Treated with Hemopurifier® Therapy
5. Aethlon Medical to Present at Todays Security Research Associates 8th Annual Growth Conference
6. Aethlon Medical (AEMD) Note: Cancer Research Discovery - Melanoma Exosomes Fuel Organ Metastasis
7. Aethlon Medical Announces Notice of Allowance of U.S. Patent Application Covering a Medical Device to Remove Microvesicular Particles, Including Exosomes
8. Aethlon Medical (AEMD) Note: Cancer Treatment Publication Authored by Aethlon Medical Researchers Now Available
9. Aethlon Medical Announces the Appointment of Thomas V. Wornham and Philip A. Ward to its Board of Directors
10. Aethlon Medical Announces Renewal of DARPA Dialysis-Like Therapeutics Contract
11. Aethlon Medical Discusses Therapeutic Device Strategies to Address Cancer, Hepatitis-C and Sepsis with the Wall Street Transcript
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... July 22, 2014  Edwards Lifesciences Corporation (NYSE: ... of heart valves and hemodynamic monitoring, announced that Edwards, ... served as an expert panelist at the invitation of ... Health to discuss medical device innovation at its hearing, ... Evidence Development and Communication." "Edwards has five ...
(Date:7/22/2014)... 22, 2014  Jazz Pharmaceuticals plc (Nasdaq: ... 2014 second quarter financial results on Tuesday, August 5, ... management will host a live audio webcast immediately following ... provide a business and financial update and discuss second ... access the live audio webcast via the Investors & ...
(Date:7/22/2014)... July 22, 2014 Research and Markets ... Culture Market by Equipment, by Reagent, by Application - ... http://photos.prnewswire.com/prnh/20130307/600769 ... culture is one of the most important and widely ... largest application segment of the cell culture market in ...
Breaking Medicine Technology:Edwards' CEO Invited To Address Congress On Opportunities To Revitalize Medical Device Innovation 2Jazz Pharmaceuticals to Report 2014 Second Quarter Financial Results on August 5, 2014 2Global Cell Culture (Bioreactor, Incubator, Centrifuge) Market - Forecast to 2018 2Global Cell Culture (Bioreactor, Incubator, Centrifuge) Market - Forecast to 2018 3
(Date:7/23/2014)... July 23, 2014 As the body ages, ... slowly resulting in old muscle being replaced by fatty tissue. ... fat in the belly region, the most dangerous area of ... actually surrounds the internal organs and circulates through the liver ... conditions. , For this reason, Diet Doc’s staff of ...
(Date:7/23/2014)... QC (PRWEB) July 23, 2014 ... the features and benefits of the company’s latest ... ASEPTIX² Dual UV Disinfection System uses a primary ... high-touch surfaces with ultraviolet ‘C’ energy controlling (6 ... C. diff. in less than 10 minutes in ...
(Date:7/23/2014)... CA (PRWEB) July 23, 2014 Woodland ... million Americans suffering from chronic bad breath that the condition ... they speak. , Dr. Saj Jivraj and Dr. Mamaly Reshad ... Hills, Calif., are concerned that some people may be overlooking ... often is a sign of an infection or chronic disease ...
(Date:7/23/2014)... ISI Telemanagement Solutions, Inc., a leading provider ... Analytics, a new product as part of their ... users the ability to uncover vital customer information buried ... well as chat sessions and social media announcements. While ... adding speech analytics on to a recording solution provides ...
(Date:7/23/2014)... Townsend Security, a leading authority in data privacy ... solutions now support two factor authentication. This major update ... on passwords as their only authentication mechanism. , Customers ... Factor Authentication software with the following Alliance solutions ... AES/400 – High performance, NIST validated AES encryption , ...
Breaking Medicine News(10 mins):Health News:Diet Doc Medical Weight Loss Programs Announces Exclusive Diet Plans for Men that are Simple, Easy to Follow and Melt Dangerous Belly Fat 2Health News:Diet Doc Medical Weight Loss Programs Announces Exclusive Diet Plans for Men that are Simple, Easy to Follow and Melt Dangerous Belly Fat 3Health News:Sanuvox Produces ASEPTIX² Movie Showcasing the Feature Benefits of the Company’s Latest Flagship Hospital Surface Disinfection System 2Health News:Woodland Hills’ Top Cosmetic Dentists Offer 6 Tips on Causes of Bad Breath That Should Concern You 2Health News:Woodland Hills’ Top Cosmetic Dentists Offer 6 Tips on Causes of Bad Breath That Should Concern You 3Health News:Woodland Hills’ Top Cosmetic Dentists Offer 6 Tips on Causes of Bad Breath That Should Concern You 4Health News:Woodland Hills’ Top Cosmetic Dentists Offer 6 Tips on Causes of Bad Breath That Should Concern You 5Health News:ISI Telemanagement Solutions, Inc. Releases Infortel® Speech Analytics 2Health News:ISI Telemanagement Solutions, Inc. Releases Infortel® Speech Analytics 3Health News:Townsend Security Brings Two Factor Authentication to Leading IBM i Security Solutions 2
... may contain higher levels of extremely small particles of ... than polluted outdoor air, scientists in Australia and Germany ... Environmental Science & Technology . Lidia Morawska ... the health effects of airborne ultrafine particles. Evidence suggests ...
... , , ATLANTA, Dec. 22 ... leader in automated revenue integrity solutions that improve healthcare providers, ... of first in the Revenue Cycle - Chargemaster Management market ... Software & Professional Services" report, published December 2009. KLAS is ...
... Dec. 22 After taking part in a ... Senators Max Baucus (D-MT), Christopher Dodd (D-CT) and Tom Harkin ... and President of the National Puerto Rican Coalition today issued ... Fantauzzi: , "We are on the threshold of legislation ...
... An international study authored by a UT Southwestern Medical ... works no better than a placebo in several other applications ... of a class of drugs used to increase red blood ... and anemia, but in a study of 4,038 patients, it ...
... mice, single treatment offered lifetime protection against inherited form of ... treatment with a new method of gene therapy may offer ... according to the results of a study in mice. , ... Alpha-1 Anti-trypsin Deficiency, caused by a mutation in the alpha-1 ...
... , , KANSAS CITY, Mo., Dec. ... financial services industry, insurance businesses have not been immune to ... companies leaked into the business side of insurance, creating skepticism ... able to plan and protect themselves and their families. ...
Cached Medicine News:Health News:Craneware's Chargemaster Toolkit(R) Earns #1 KLAS Rank for Fourth Consecutive Year 2Health News:Craneware's Chargemaster Toolkit(R) Earns #1 KLAS Rank for Fourth Consecutive Year 3Health News:National Puerto Rican Coalition Urges Passage of Senate Health Bill 2Health News:Anemia drug not helpful for kidney disease patients 2Health News:Gene Therapy Holds Promise for Emphysema 2Health News:After Tough 2009, Improved Accountability and Consistent Insurance Industry Standards Key in 2010 2Health News:After Tough 2009, Improved Accountability and Consistent Insurance Industry Standards Key in 2010 3Health News:After Tough 2009, Improved Accountability and Consistent Insurance Industry Standards Key in 2010 4
The Surgiflex WAVE XP couples the state-of-the-art Surgiflex WAVE Probe with the convenience of a truly portable battery-powered pump....
... a minimally invasive, highly effective surgical alternative ... GYNECARE TVT is positioned close to the ... when needed, TVT provides tension-free support of ... procedure takes approximately 20 to 30 minutes, ...
... best of both worlds, the PeaceKeeper ... the latest addition to the Wet-Field ... cautery instruments for ophthalmic surgery. Combining ... aspiration and backflush functionality in a ...
...
Medicine Products: